Dermapharm
€45.65
50
-€0.55-1.19% Monday 15:30
Statistics
Day High
46.25
Day Low
45.65
52W High
47.25
52W Low
32.05
Volume
205,466
Avg. Volume
-
Mkt Cap
0
P/E Ratio
21.49
Dividend Yield
1.9%
Dividend
0.87
Upcoming
Dividends
1.9%Dividend Yield
Jul 25
€0.9
Jul 24
€0.88
Jun 23
€1.05
Jun 21
€0.88
Jun 19
€0.77
10Y Growth
N/A
5Y Growth
0.45%
3Y Growth
-5.01%
1Y Growth
N/A
Earnings
13MayExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
9.64%Profit Margin
Profitable2.36BRevenue
227.57MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow DMP.XETRA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap293.34B
Pfizer
PFE
Mkt Cap156.77B
Merck
MRK
Mkt Cap294.39B
GSK
GSK
Mkt Cap117.55B
Johnson & Johnson
JNJ
Mkt Cap564.35B
Sanofi
SNY
Mkt Cap115.14B
Abbvie
ABBV
Mkt Cap368.57B
Roche
RHHBY
Mkt Cap330.22B
Teva- Pharmaceutical Industries
TEVA
Mkt Cap38.65B
About
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
Show more...
CEO
Dr. Hans-Georg Feldmeier
Employees
3610
Country
Germany
ISIN
DE000A2GS5D8
WKN
000A2GS5D
Listings
0 Comments
Share your thoughts
FAQ
What is Dermapharm stock price today?▼
The current price of DMP.XETRA is €45.65 EUR — it has decreased by -1.19% in the past 24 hours. Watch Dermapharm stock price performance more closely on the chart.
What is Dermapharm stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dermapharm stocks are traded under the ticker DMP.XETRA.
Is Dermapharm stock price growing?▼
DMP.XETRA stock has risen by +0.44% compared to the previous week, the month change is a +11.61% rise, over the last year Dermapharm has showed a +25.07% increase.
When is the next Dermapharm earnings date?▼
Dermapharm is going to release the next earnings report on May 13, 2026.
What were Dermapharm earnings last quarter?▼
DMP.XETRA earnings for the last quarter are 0.7 EUR per share, whereas the estimation was 0.41 EUR resulting in a +68.29% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Dermapharm revenue for the last year?▼
Dermapharm revenue for the last year amounts to 2.36B EUR.
What is Dermapharm net income for the last year?▼
DMP.XETRA net income for the last year is 227.57M EUR.
Does Dermapharm pay dividends?▼
Yes, DMP.XETRA dividends are paid annual. The last dividend per share was 0.9 EUR. As of today, Dividend Yield (FWD)% is 1.9%.
How many employees does Dermapharm have?▼
As of April 21, 2026, the company has 3,610 employees.
In which sector is Dermapharm located?▼
Dermapharm operates in the Health & Wellness sector.
When did Dermapharm complete a stock split?▼
Dermapharm has not had any recent stock splits.
Where is Dermapharm headquartered?▼
Dermapharm is headquartered in Grünwald, Germany.